Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yuliya O. Davydova"'
Autor:
Elena N. Parovichnikova, Irina A. Lukianova, Vera V. Troitskaya, Mikhail Yu. Drokov, Larisa A. Kuzmina, Andrei N. Sokolov, Alina V. Kokhno, Zalina T. Fidarova, Irina V. Galtseva, Yuliya O. Davydova, Anastasiia I. Kashlakova, Elena O. Gribanova, Eugene E. Zvonkov, Elena P. Sysoeva, Valentina N. Dvirnyk, Tatiana N. Obukhova, Andrei B. Sudarikov, Yuliya V. Sidorova, Sergei M. Kulikov, Yuliia A. Chabaeva, Valerii G. Savchenko
Publikováno v:
Терапевтический архив, Vol 93, Iss 7, Pp 753-762 (2021)
Aim. To analyze the results of treatment in patients with acute myeloid leukemia (AML) within protocols AML-17 and modified AML-17 (mOML-17) as part of two consecutive pilot studies in order to develop the best treatment strategy for AML patients age
Externí odkaz:
https://doaj.org/article/ead7e57f92e747e7b74baee842d7e924
Autor:
Valeriy G. Savchenko, Sergei M. Kulikov, Vera Vasilieva, M V Dovydenko, Larisa A. Kuzmina, Nina Drize, Nataliya Petinati, Y A Chabaeva, Natalia Sats, Mikhail Yu. Drokov, T V Gaponova, Elena N. Parovichnikova, Nikolay M. Kapranov, Yuliya O. Davydova
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 23-30 (2020)
Analysis of the effectiveness of the MSCs aministration as the second- or third-line therapy of acute GVHD (aGVHD) resistant to glucocorticosteroid treatment.The study included 35 patients who received MSCs obtained from the bone marrow of healthy do
Autor:
A E Krasilnikova, Vera V. Troitskaya, G A Baskhaeva, Andrey Sudarikov, Yuliya O. Davydova, Sergey N. Bondarenko, A N Sokolov, Valery G. Savchenko, B V Biderman, Olga A. Gavrilina, Elena N. Parovichnikova, Irina V. Galtseva, K. I. Zarubina
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 110-117 (2018)
B-cell acute lymphoblastic leukemia (B-ALL) is a diverse group of malignant blood disorders both with regard to the biological properties of the tumor and to therapeutic approaches. Immunophenotyping, molecular genetic techniques, whole-genome sequen
Autor:
Elena K. Egorova, Olga A. Soboleva, Elena I Pustovaya, Karen I. Ntanisian, Yuliya O. Davydova, Valeriy G. Savchenko, Nikolay M. Kapranov, Irina V. Galtseva, Kseniya A. Nikiforova, Anait L. Melikyan
Publikováno v:
Blood. 136:4-5
Introduction Immune thrombocytopenic purpura (ITP), or primary immune thrombocytopenia is an autoimmune disease characterized by isolated thrombocytopenia (number of platelets in peripheral blood is less than 100×109/L) and splenic production of ant
Autor:
Lubov Grebenyuk, Murat Vagida, Elena A. Mikhaylova, Tatiana N. Obukhova, Yuliya O. Davydova, Tatiana I. Lobanova, Anton V. Luchkin, Anastasia V. Abramova, Alina E. Krasilnikova, Valery G. Savchenko, Elena N. Parovichnikova, Irina V. Galtseva, Vera V. Troitskaya, Zalina T. Fidarova, Nikolay M. Kapranov
Publikováno v:
Blood. 132:5108-5108
Background. New insight into pathogenesis of aplastic anemia (AA) in conjunction with effectiveness of Eltrombopag allowes to recommend it for initial treatment of de novo AA. However, eltrombopag was an attractive option for patients at different st
Autor:
Tatiana I. Lobanova, Elena N. Parovichnikova, Larisa A. Kuzmina, Irina V. Galtseva, Valery G. Savchenko, Sergei M. Kulikov, Irina A. Lukyanova, Yuliya O. Davydova, Nikolay M. Kapranov, Vera V. Troitskaya
Publikováno v:
Blood. 132:2808-2808
Introduction. Minimal residual disease (MRD) detection by multicolor flow cytometry (MFC) after early induction or consolidation AML therapy is a well known factor of adverse prognosis, especially in intermediate risk group. New assessment of respons
Autor:
Irina A. Lukyanova, Andrey N. Sokolov, Valery G. Savchenko, Roman V. Tivikov, Tatiana N. Obukhova, Nikolay M. Kapranov, Tatiana I. Lobanova, Vera V. Troitskaya, Irina V. Galtseva, A V Kokhno, Elena N. Parovichnikova, Yuliya O. Davydova
Publikováno v:
Blood. 132:1495-1495
Background. The recent ELN recommendations (2017) have introduced new criteria of response in AML - complete remission with MRD-negativity (CR/MRD-neg). It's a well-known fact that AML with different cytogenetics has different chemosensitivity, and s
Autor:
Maria V. Bakshinskayte, Elena N. Parovichnikova, Irina V. Galtseva, Nataliya Petinati, Nikolay M. Kapranov, Yuliya O. Davydova, Nina Drize, Valeriy G. Savchenko, Larisa A. Kuzmina
Publikováno v:
Blood. 128:5722-5722
Multipotent mesenchymal stromal cells (MSCs) have immunomodulatory properties and have been successfully used for treatment of autoimmune diseases and acute or chronic graft-versus-host disease. Therapy with MSCs is not always effective. It has been